Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: Poor adherence and the need to address it

Journal of Cystic Fibrosis

Volumn 9, Issue 6, 2010, Pages 455-456

  Duff, Alistair J A ^a   Latchford, Gary J ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; AZTREONAM LYSINE; DENUFUSOL; DORNASE ALFA; MANNITOL; UNCLASSIFIED DRUG;

CYSTIC FIBROSIS; INHALATIONAL DRUG ADMINISTRATION; LETTER; LUNG DISEASE; NEBULIZER; PATIENT COMPLIANCE;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; EXPECTORANTS; HUMANS; LUNG DISEASES; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; PNEUMONIA, BACTERIAL;

EID: 78650214489     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.08.012     Document Type: Letter

References (11)

1. Heijerman H., Westerman E., Conway S., Touw D., Doring G. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J Cyst Fibrosis 2009, 8:295-315.
2. Rottier B.L., de Boer A.H., Duiverman E.J. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: three areas for future research. Which areas to target? Which particle size to deliver? Which device to use?. J Cyst Fibrosis 2010, 9:296-297.
3. Latchford G.J., Duff A.J.A., Quinn J., Conway S., Conner M. Adherence to nebulised antibiotics in cystic fibrosis. Pat Educ & Couns 2009, 75:141-144.
4. McNamara P.S., McCormack P., McDonald A.J., Heaf L., Southern K.W. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. J Cyst Fibrosis 2009, 8:258-263.
5. Bernard R.S., Cohen L.L. Increasing adherence to cystic fibrosis treatment: a systematic review of behavioural techniques. Ped Pulmonol 2004, 37:8-16.
6. Mead N., Bower P. Patient-centred consultations and outcomes in primary care: a review of the literature. Pat Educ & Couns 2002, 48:51-61.
7. DiMatteo M.R., Giordani P.J., Lepper H.S., Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002, 40:794-811.
8. Kelly J.A., Kalichman S.C. Behavioral research in HIV/AIDS primary and secondary prevention: recent advances and future directions. J Consult Clin Psychol 2002, 70:626-639.
9. Duff A.J.A., Latchford G.J. Motivational Interviewing for adherence problems in cystic fibrosis: state of the art review. Ped Pulmonol 2010, 45:211-220.
10. Quinn J., Latchford G.L., Duff A.J.A., Conner M., Pollard K. Measuring, predicting and improving adherence to inhalation therapy in patients with CF: a randomised controlled study of motivational interviewing. Ped Pulmonol 2004, Suppl 31:360.
11. Moran J., Bekker H.L., Latchford G.J. Everyday use of patient-centred, motivational techniques in routine consultations between doctors and patients with diabetes. Patient Educ Couns 2008, 73:224-231.